RU2021116339A - VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS - Google Patents

VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS Download PDF

Info

Publication number
RU2021116339A
RU2021116339A RU2021116339A RU2021116339A RU2021116339A RU 2021116339 A RU2021116339 A RU 2021116339A RU 2021116339 A RU2021116339 A RU 2021116339A RU 2021116339 A RU2021116339 A RU 2021116339A RU 2021116339 A RU2021116339 A RU 2021116339A
Authority
RU
Russia
Prior art keywords
streptococcus suis
antigen
serotype
pigs
igm protease
Prior art date
Application number
RU2021116339A
Other languages
Russian (ru)
Other versions
RU2802072C2 (en
Inventor
Антониус Арнольдус Кристиан ЯКОБС
Original Assignee
Интервет Интернэшнл Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Интервет Интернэшнл Б.В. filed Critical Интервет Интернэшнл Б.В.
Publication of RU2021116339A publication Critical patent/RU2021116339A/en
Application granted granted Critical
Publication of RU2802072C2 publication Critical patent/RU2802072C2/en

Links

Claims (9)

1. Антиген протеазы IgM Streptococcus suis для применения в способе защиты свиней против патогенной инфекции Streptococcus suis серотипа 2 и против патогенной инфекции Streptococcus suis серотипа 14.1. Streptococcus suis IgM protease antigen for use in a method for protecting pigs against pathogenic infection of Streptococcus suis serotype 2 and against pathogenic infection of Streptococcus suis serotype 14. 2. Антиген протеазы IgM для применения по п.1, отличающийся тем, что способ включает введение антигена свиньям только один раз.2. IgM protease antigen for use according to claim 1, characterized in that the method comprises administering the antigen to pigs only once. 3. Антиген протеазы IgM для применения по любому из пп. 1 или 2, отличающийся тем, что способ включает введение антигена свиньям в возрасте не более 28 суток.3. IgM protease antigen for use according to any one of paragraphs. 1 or 2, characterized in that the method includes the introduction of the antigen to pigs aged no more than 28 days. 4. Антиген протеазы IgM для применения по любому из пп. 1-3, отличающийся тем, что способ включает введение антигена до возраста отнятия поросят.4. IgM protease antigen for use according to any one of paragraphs. 1-3, characterized in that the method includes the introduction of antigen before the age of weaning piglets. 5. Антиген протеазы IgM для применения по любому из пп. 1-4, отличающийся тем, что способ включает введение антигена свиньям, имеющим антитела против Streptococcus suis материнского происхождения.5. IgM protease antigen for use according to any one of paragraphs. 1-4, characterized in that the method includes the introduction of the antigen to pigs having antibodies against Streptococcus suis of maternal origin. 6. Антиген протеазы IgM для применения по любому из пп. 1-5, отличающийся тем, что способ предназначен для обеспечения защиты против смертности, ассоциированной с патогенной инфекцией Streptococcus suis серотипа 2 и серотипа 14.6. IgM protease antigen for use according to any one of paragraphs. 1-5, characterized in that the method is designed to provide protection against mortality associated with pathogenic infection with Streptococcus suis serotype 2 and serotype 14. 7. Антиген протеазы IgM для применения по любому из пп. 1-6, отличающийся тем, что способ предназначен для обеспечения защиты против клинических признаков, ассоциированных с патогенной инфекцией Streptococcus suis серотипа 2 и серотипа 14.7. IgM protease antigen for use according to any one of paragraphs. 1-6, characterized in that the method is designed to provide protection against clinical signs associated with pathogenic infection with Streptococcus suis serotype 2 and serotype 14. 8. Применение антигена протеазы IgM Streptococcus suis для получения вакцины для защиты свиней против патогенной инфекции Streptococcus suis серотипа 2 и против патогенной инфекции Streptococcus suis серотипа 14.8. Use of Streptococcus suis IgM protease antigen to obtain a vaccine to protect pigs against pathogenic infection of Streptococcus suis serotype 2 and against pathogenic infection of Streptococcus suis serotype 14. 9. Способ защиты свиней против патогенной инфекции Streptococcus suis серотипа 2 и против патогенной инфекции Streptococcus suis серотипа 14 путем введения свиньям вакцины, содержащей антиген протеазы IgM Streptococcus suis.9. Method for protecting pigs against pathogenic Streptococcus suis serotype 2 infection and against pathogenic Streptococcus suis serotype 14 infection by administering to pigs a vaccine containing Streptococcus suis IgM protease antigen.
RU2021116339A 2018-11-08 2019-11-07 Vaccine for protection against streptococcus suis RU2802072C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18205251.4 2018-11-08

Publications (2)

Publication Number Publication Date
RU2021116339A true RU2021116339A (en) 2022-12-08
RU2802072C2 RU2802072C2 (en) 2023-08-22

Family

ID=

Similar Documents

Publication Publication Date Title
RU2020119271A (en) VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS
PT714444E (en) ATENUATION OF AN IMMUNODOMINANT EPITOPO OF AN ANTIGEN FOR USE IN VACCINES AND IMMUNOTHERAPIES FOR PLANTS, ANIMALS AND MEN
EP0090581A3 (en) Small peptides with the specificity of foot and mouth disease viral antigens
RU2020109137A (en) VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS
Paton et al. Foetal cross-protection experiments between type 1 and type 2 bovine viral diarrhoea virus in pregnant ewes
SE7512828L (en) CALICIVIRUSVACCIN
RU2021116339A (en) VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS
Elzein et al. Severe Long‐Lasting Contagious Ecthyma Infection in a Goat's Kid
MX2020006061A (en) A vaccine for protection against streptococcus suis.
GB1071922A (en) Improvements in or relating to vaccines
CO2022007006A2 (en) Triple vaccine against avibacterium paragallinarum and avian encephalomyelitis virus and fowlpox virus
ES2059305T3 (en) PROTEIN OF THE VIRUS OF THE SEUDORRABIA.
BR112018074114A2 (en) hev vaccine
RU2024105296A (en) VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF DIFFERENT SEROTYPES
RU2024105210A (en) VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF DIFFERENT SEROTYPES
Malmarugan et al. Diagnosis and therapeutic management of goat pox in ovines
RU2024105315A (en) VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF DIFFERENT SEROTYPES
Castrucci et al. Neonatal calf diarrhea induced by rotavirus
BR112017004703A2 (en) Vaccine and method for protecting a sow's progeny against infection with a swine endemic diarrhea virus?
RU2017130459A (en) VACCINE FOR LAWSONIA SUBCLINICAL INFECTION IN PIGS
KR900017611A (en) Corona Antivirus for Dogs
RU2010120755A (en) VACCINE ASSOCIATED AGAINST VARVIRUS, REOVIRUS, HERPESVIRUS TYPE I INFECTIONS AND VIRAL DIARRHEA - MULTI CATALOG DISEASES INACTIVATED
Chang-Seon Augmented immune responses in pigs immunized with an inactivated porcine reproductive and respiratory syndrome virus containing the deglycosylated glycoprotein 5 under field conditions
RU2018118175A (en) VACCINE FOR PROTECTING MDA-POSITIVE ANIMAL AGAINST DISORDER ARISING FROM INFECTION CAUSED BY LAWSONIA INTRACELLULARIS
GB1061898A (en) Method for protecting dogs against canine distemper